The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

VER VERNALIS PLC ORD 1P




 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
13:27 30-Jun-2015 VER Appointment of Non-Executive Director RNS -2.05% Down
07:00 30-Jun-2015 VER Total Voting Rights RNS -2.05% Down
16:34 12-Jun-2015 VER Holding(s) in Company RNS -2.37% Down
07:00 11-Jun-2015 VER CCP-07 starts 12 month stability testing RNS -2.23% Down
13:45 06-May-2015 VER Block Listing Six Monthly Review RNS +10.65% Up
12:30 06-May-2015 VER Director/PDMR Shareholding RNS +10.65% Up
16:38 01-May-2015 VER Holding(s) in Company RNS +22.54% Up
07:00 01-May-2015 VER FDA approves NDA for Tuzistra XR RNS +22.54% Up
15:27 30-Apr-2015 VER Holding(s) in Company RNS +19.76% Up
14:39 23-Apr-2015 VER Holding(s) in Company RNS +2.31% Up
07:00 07-Apr-2015 VER Vernalis enters into research collaboration RNS -0.16% Down
12:47 31-Mar-2015 VER Total Voting Rights RNS +0.87% Up
07:00 06-Mar-2015 VER Vernalis and AKP Achieve Research Milestone RNS +0.37% Up
07:00 26-Feb-2015 VER Vernalis licenses proprietary ARA technology RNS +3.06% Up
12:51 18-Feb-2015 VER Holding(s) in Company RNS -3.60% Down
07:00 10-Feb-2015 VER Unaudited interim results for periods to 31/12/14 RNS -3.25% Down
17:53 05-Feb-2015 VER Holding(s) in Company RNS -0.65% Down
11:50 30-Jan-2015 VER Notice of Interim Results Period Ended 31 Dec 2014 RNS +1.21% Up
13:06 26-Jan-2015 VER Holding(s) in Company RNS -0.50% Down
11:00 21-Jan-2015 VER Change of Non-Executive Director RNS -0.60% Down

 Page 1 of 3

| 1 | 2 | 3 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address 100 Berkshire Place, Wharfedale Road, Winnersh, RG41 5RD, United Kingdom
Company website http://www.vernalis.com
Market cap(in millions)* £ 302.85
Listing/Admission to trading 27 Apr 2012
Trading service -
Market -
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
04-Jul-15
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



VERNALIS share - news analysis